Target (CBDY) Equity Average (2014 - 2026)
Target (CBDY) reported Equity Average of -$8.3 million for Q1 2026, down 26.52% year-over-year from -$11.3 million in Q1 2025, and down 7.16% quarter-over-quarter from -$7.7 million in Q4 2025.
Target (CBDY) Equity Average (2014 - 2026) Analysis & Trends
Target (CBDY) has 13 years of Equity Average data on file, last reported at -$8.3 million in Q1 2026.
- Equity Average for Q1 2026 came in at -$8.3 million, down 26.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.3 million (down 26.52% YoY), and the FY2025 annual result was -$7.3 million, down 8.09% from the prior year.
- Equity Average fell to -$8.3 million in Q1 2026 per CBDY's latest filing, from -$7.7 million in the prior quarter.
- Over five years, Equity Average peaked at -$2.4 million in Q1 2022 and troughed at -$8.3 million in Q1 2026.
- A 5-year average of -$6.1 million and a median of -$6.8 million in 2024 frame the typical range for Equity Average.
- The sharpest annual moves came in 2022 and 2023: Equity Average surged 45.47% in 2022, then tumbled 185.69% in 2023.
- A 5-year view of Equity Average shows it stood at -$4.7 million in 2022, then plunged by 48.01% to -$6.9 million in 2023, then gained by 2.34% to -$6.8 million in 2024, then slipped by 14.75% to -$7.7 million in 2025, then declined by 7.16% to -$8.3 million in 2026.
- Business Quant data shows CBDY's Equity Average at -$8.3 million in Q1 2026, -$7.7 million in Q4 2025, and -$7.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.15 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 493.55 Mn |
| 10 | Target | - | - | 191,787.00 | -8.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.30 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Sep 30, 2025 | -7.23 Mn |
| Jun 30, 2025 | -6.82 Mn |
| Mar 31, 2025 | -6.56 Mn |
| Dec 31, 2024 | -6.75 Mn |
| Sep 30, 2024 | -6.70 Mn |
| Jun 30, 2024 | -6.73 Mn |
| Mar 31, 2024 | -7.02 Mn |
| Dec 31, 2023 | -6.91 Mn |
| Sep 30, 2023 | -6.71 Mn |
| Jun 30, 2023 | -6.94 Mn |
| Mar 31, 2023 | -6.93 Mn |
| Dec 31, 2022 | -4.67 Mn |
| Sep 30, 2022 | -2.63 Mn |
| Jun 30, 2022 | -2.59 Mn |
| Mar 31, 2022 | -2.43 Mn |
| Dec 31, 2021 | -2.13 Mn |
| Sep 30, 2021 | -3.17 Mn |
| Jun 30, 2021 | -4.75 Mn |